Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Noncoding RNA Res ; 9(3): 921-929, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38660591

RESUMO

Colorectal cancer (CRC) incidence ranks third among malignant cancers with a high propensity for distant metastasis. Despite continuous efforts to improve treatment, the prognosis especially in patients with advanced distant metastasis is low. The mechanism of development and progression of CRC is not fully understood. Non-coding RNAs (ncRNAs) have emerged as essential regulators in cancer progression. Here, we aim to dissect the role of one critical ncRNA, circANXA4, in CRC progression. CircANXA4 expression was analyzed by the GEO database. Differentially expressed circRNAs were identified by the Limma package R software. Expression of circANXA4 and miR-1256 was detected by qRT-PCR. The regulation of circANXA4 on cell proliferation and progression was confirmed with the cell viability assay using cell counting kit-8 (CCK-8) and transwell migration assay. RNA pull-down assay, RNA immunoprecipitation (RIP), and western blot were used to determine the interaction between circANXA4, miR-1256, and protamine1 (PRM1). CircANXA4 was upregulated in both CRC tissues and cell lines. Knockdown of circANXA4 effectively reduced cell proliferation, progression, and migration. Additionally, silencing circANXA4 remarkably increased miR-1256 expression, while reducing PRM1 expression, thereby demonstrating that circANXA4 downregulates miR-1256 expression through a complementary binding site. Rescue experiments revealed the interactions between circANXA4, miR-1256, and PRM1. Pearson correlation analysis revealed that circANXA4 expression positively correlated with PRM1 expression and miR-1256 expression inversely correlated with PRM1 expression. In sum, we demonstrated that circANXA4 promotes cancer cell proliferation and progression by sponging miR-1256 and upregulating PRM1 in CRC.

2.
Biochem Genet ; 62(2): 1182-1199, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37561333

RESUMO

Circular RNAs (circRNAs) play regulatory roles in the biological processes of multiple tumors, colorectal cancer (CRC) included. Our previous study probed the impact of circ_0007385 on CRC cell malignant behaviors, while the underlying mechanism remains obscure. In this work, the potential mechanism of hsa_circ_0007385 in CRC was probed. Functional experiments were implemented for probing the function of hsa_circ_0007385 in CRC. Further analysis revealed the relation between hsa_circ_0007385 and miRNAs. A xenograft mouse model was implemented for probing the influence of hsa_circ_0007385 on CRC growth and metastasis in vivo. Hsa_circ_0007385 was up-regulated in CRC. Hsa_circ_0007385 positively regulated its host gene mediator of cell motility 1 (MEMO1). Hsa_circ_0007385 silencing inhibited CRC progression. Hsa_circ_0007385 and MEMO1 bond to miR-485-3p/miR-543/miR-337-3p, and these three miRNAs were lowly expressed in CRC, and negatively modulated by hsa_circ_0007385. Hsa_circ_0007385 functioned as an oncogene in CRC in a miR-485-3p/miR-543/miR-337-3p- or MEMO1-dependent manner. Hsa_circ_0007385 promoted CRC progression via modulating miR-485-3p/miR-543/miR-337-3p/MEMO1 axis. Thus, circ-MEMO1 might be a promising therapeutic target for CRC.

3.
Exp Brain Res ; 241(2): 395-406, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36562806

RESUMO

We aim to research the molecular mechanism of lncRNA NEAT1 in the activation of astrocytes in a cerebral ischemia-reperfusion injury model. Mouse model of cerebral ischemia-reperfusion injury was constructed, and shNEAT1 was transfected. The infarct area, brain water content, and neurological deficiency were detected. Immunofluorescence detection and fluorescence in situ hybridization (FISH) assay were processed to detect glial fibrillary acidic protein (GFAP) expression. Astrocyte cells were cultured for oxygen-glucose deprivation/re-oxygenation (OGD)/re-oxygenation model construction. After treatment by shNEAT1, miR-488-3p mimic, miR-488-3p inhibitor, Q-PCR assay, western blot and ELISA were undertaken to detect the expressions of NEAT1, miR-488-3p, RAC1, inflammatory cytokines, RAC1 and GFAP. Dual luciferase reporter assay and RNA-binding protein immunoprecipitation (RIP) assay were used to verify the binding of NEAT1, miR-488-3p and RAC1. The expression of NEAT1 in brain tissue was significantly higher than that in Sham operation group. Knockdown of NEAT1 inhibited the brain damage caused by middle cerebral artery occlusion (MCAO) treatment, reduced the inflammatory response, and suppressed the activation of astrocytes. By constructing an in vitro OGD/R cell model, it was found that NEAT1 knockdown also inhibited the activation of astrocytes caused by OGD/R. Knockdown of NEAT1 caused the up-regulation of miR-488-3p and the down-regulation of RAC1. Knockdown of miR-488-3p or over-expression of RAC1 reversed the inhibitory effect of shNEAT1 on OGD/R-induced astrocyte activation. Over-expression of NEAT1 in cerebral ischemic stroke promotes activation of astrocytes by modulation miR-488-3p/RAC1, which is proved in vitro. Our study may provide a new idea for the diagnosis and treatment of MCAO.


Assuntos
Isquemia Encefálica , AVC Isquêmico , MicroRNAs , RNA Longo não Codificante , Traumatismo por Reperfusão , Acidente Vascular Cerebral , Camundongos , Animais , Regulação para Cima , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Astrócitos/metabolismo , Hibridização in Situ Fluorescente , MicroRNAs/genética , MicroRNAs/metabolismo , Acidente Vascular Cerebral/genética , Isquemia Encefálica/genética , Infarto da Artéria Cerebral Média , Apoptose/genética
4.
J Colloid Interface Sci ; 562: 193-203, 2020 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-31838355

RESUMO

While orthorhombic niobium pentoxide (T-Nb2O5) is one of the most promising energy storage material with rapid lithium ion (Li+) intercalation pseudocapacitive response, a key challenge remains the achievement of high-rate charge-transfer reaction when fabricated into thick electrodes. Herein, we report a facile method to create intrinsic defects in T-Nb2O5 through a hydrogen (H2) reduction, which is effective to overcome the limitations of electrochemical utilization and rate capability. Due to the high number of active sites introduced, the specific capacity of hydrogenated (H-) Nb2O5 with oxygen vacancies reaches 649 C g-1 at 0.5 A g-1, greatly exceeding that of T-Nb2O5 which is 580 C g-1. In addition, theformation of oxygen vacancies leads to increased donor density and enhanced electrical conductivity, which accelerates charge storage kinetics and enables excellent long-term cycling stability (86% retention after 2000 cycles). The analysis of electrochemical impedance spectroscopy (EIS) plots and the calculation of Li+ diffusion coefficients (DLi) further explains the high rate-performance of H-Nb2O5. When the electrode thickness increased to 150 µm, the H-Nb2O5 still delivers excellent electrochemical properties. Therefore, the introduction of oxygen vacancies provides a new method towards the improvement of the electrochemical properties of various transition metal oxides.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA